Prof Marina Kleanthous, Head of the Molecular Genetics Thalassaemia Department (MGTD) of the Cyprus Institute of Neurology and Genetics (CING), has extensive experience in the diagnosis, prenatal diagnosis, non-invasive prenatal diagnosis (NIPD) and preimplantation genetic diagnosis (PGD) of haemoglobinopathies and other single gene disorders.
Her research interests include drug therapy for thalassaemia using HbF inducers, the development of biomarkers using omics technologies, GWAS and gene therapy for haemoglobin disorders by gene augmentation and correction. She is the coordinator of the ITHANET portal, member of the ERN EuroBloodNet, and in charge of designing and developing the Rare Anaemias Disorders European Epidemiological Platform (RADeep).
She is a partner of the HVP initiative Global Globin 2020 Challenge (GG2020) and she coordinates the Haemoglobinopathy Expert Panel. She is WP leader/partner in National and EU projects (ARISE, an H2020 MSCA RISE project, EPTRI RI, GenoMed4All).